Search
In the field of cancer research, lobbying efforts by the The Kids Cancer Centre have contributed to major initiatives including Australia’s first personalised medicine program for children with high-risk cancer, and a mission to boost survival rates in brain cancer patients.
Australian Lions Childhood Cancer Research Foundation has announced it will provide $1.05 million of funding to The Kids Research Institute Australia.
The Kids Research Institute Australia and Perth Children’s Hospital will lead an international clinical trial of a novel drug combination they hope will increase cure rates for one of the most aggressive forms of childhood brain cancer.
We strive for a future where no child will die from brain cancer because we have developed new therapies that will cure their disease.
The Kids cancer researcher & clinician Dr Nick Gottardo has been announced as the recipient of an Innovation Grant from the Cure Brain Cancer Foundation.
Australian children diagnosed with a brain tumour now have a better chance of accessing the best treatment for their disease thanks to a trans-Tasman collaboration spearheaded by The Kids Research Institute Australia cancer researcher Professor Nick Gottardo.
A major gap in tackling the mental health crisis in WA is the inability to effectively treat children and adolescents with a history of trauma within the current system.
Life imitates art in a new project that seeks to entrench cultural safety for young Aboriginal and Torres Strait Islander people into WA’s mental health system.
Helping children build resilience and cope with the trauma associated with medical emergencies and chronic health conditions is the focus of a promising pilot program being undertaken by The Kids Research Institute Australia.
On this Research Impact page, we showcase real game-changers - research that changes the very way other scientists around the world think and approach challenges. The far-reaching impact on children and families for all the stories shown on these pages is both exciting and significant.